Allergen immunotherapy during the COVID-19 pandemic : A survey of the German Society for Allergy and Clinical Immunology

Allergen immunotherapy during the COVID-19 pandemic : A survey of the German Society for Allergy and Clinical Immunology

Background: When the coronavirus pandemic 2019 (COVID-19) emerged, concerns were also raised regarding the safety of allergen immunotherapy (AIT). The German Society for Allergology and Clinical Immunology (DGAKI) conducted a survey to collect real-world data on the daily routine of administerin...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Pfaar, Oliver, Hamelmann, Eckard, Klimek, Ludger, Taube, Christian, Vogelberg, Christian, Wagenmann, Martin, Werfel, Thomas, Worm, Margitta
Format: Article
Langue:anglais
Publié: Philipps-Universität Marburg 2023
Sujets:
safety
Medizin
COVID‐19
allergen immunotherapy
SARS‐CoV‐2
pandemic
survey
Medical sciences Medicine
Accès en ligne:Texte intégral en PDF
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

Texte intégral en PDF

Informations d'exemplaires de
Cote: urn:nbn:de:hebis:04-es2023-00398
Date de publication: 2023-04-04
Source: Erstveröffentlichung: Pfaar O, Hamelmann E, Klimek L, et al. Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology. Clin Transl Allergy. 2022;e12134. https://doi.org/10.1002/clt2.12134
Downloads: 28 (2024), 35 (2023)
Lizenz: https://creativecommons.org/licenses/by/4.0
URL d'accès: https://archiv.ub.uni-marburg.de/es/2023/0039
https://doi.org/10.1002/clt2.12134

Documents similaires